AGTR1 and neoplasm: Meanwhile, in cholangiocarcinoma, AT1R blockade attenuated angiogenesis by suppressing oncogenic YAP/TEAD signalling, revealing Hippo‐pathway crosstalk that may shape tumour‐specific vascular phenotypes [85].